GMED files Form 144 to sell 20,000 shares

GMED submitted a notice of proposed sale for 20,000 common shares via a cashless stock option exercise dated 02/25/2026.

Rhea-AI Filing Summary

GMED submitted a notice of proposed sale for 20,000 common shares via a cashless stock option exercise dated 02/25/2026. The filing lists shares outstanding 135,253,051 as of 02/25/2026. It also discloses prior sales by Kelly Huller: 10,000 shares on 02/12/2026 for $876,000 and 7,500 shares on 11/25/2025 for $674,619.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the GMED Form 144 disclose about the current proposed sale?

It reports a proposed sale of 20,000 common shares by cashless stock option exercise on 02/25/2026. The notice identifies the method as a Cashless Exercise and lists the transaction date and share quantity explicitly.

Who sold shares recently according to the GMED filing?

The filing shows recent sales by Kelly Huller: 10,000 shares sold on 02/12/2026 for $876,000 and 7,500 shares sold on 11/25/2025 for $674,619. These are reported prior dispositions.

How many GMED shares were outstanding as reported in the filing?

The filing lists shares outstanding 135,253,051 as of 02/25/2026. This number appears on the form and provides a company share count tied to the same date as the proposed sale.

What sale method is indicated for the 20,000 GMED shares?

The method is a Cashless Stock Option Exercise by the issuer, dated 02/25/2026. The form labels the transaction as a cashless exercise and records the issuer as the party for that specific 20,000-share entry.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 03:41 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001768417
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GLOBUS MEDICAL INC
SEC File Number	001-35621
Address of Issuer	2560 GENERAL ARMISTEAD AVENUE AUDUBON PENNSYLVANIA 19403
Phone	610-930-1800
Name of Person for Whose Account the Securities are To Be Sold	Huller Kelly
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	20000	1889000.00	135253051	02/25/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/25/2026	Cashless Stock Option Exercise	Issuer			20000	02/25/2026	Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kelly Huller 101 Eaglet Ln Schwenksville PA 19473	Common	02/12/2026	10000	876000.00
Kelly Huller 101 Eaglet Ln Schwenksville PA 19473	Common	11/25/2025	7500	674619.00

144: Remarks and Signature

Remarks
Date of Notice	02/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Kelly G Huller
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)